test

The NLA's Foundations of Lipidology course, formerly Lipid Academy, provides an introductory review of the core curriculum in Clinical Lipidology. This course is designed for any healthcare professional seeking to learn the fundamentals of Lipidology. Experts in Lipidology will lecture on basic concepts and guide participants through interactive learning scenarios that provide the knowledge and tools necessary to work effectively in a lipid practice, and prepare for advanced training.

This course is particularly useful to review core elements of Clinical Lipidology and is appropriate for clinicians from the full spectrum of clinical experience including Physicians, Physician Assistants, Nurse Practitioners, Pharmacist, Exercise Physiologists, and Dietitians who are in any phase of training, or even experienced physicians who are looking to take a deeper dive into Lipidology.

The Foundations of Lipidology is offered as a 2-day course prior to NLA meetings (Clinical Lipid Updates [CLU] and Scientific Sessions).

2025 Course Dates:

  • March 3 - 4, 2025 | Virtual | Online/Zoom Register
  • May 29 – 30, 2025 | In-Person | Miami, FL Register
  • Fall CLU Dates TBD

 

Course Curriculum

  • Lipids, Lipoproteins and Atherosclerosis
  • Landmark Clinical Trials
  • Dyslipidemia and Inherited Lipid Abnormalities
  • Pharmacologic Therapies
  • Therapeutic Lifestyle Changes
  • Specific Populations Diagnosis and Therapeutic Considerations
  • Overview of Clinical Guidelines in Lipid Management
  • Challenging Patient Cases   

Target Audience
This activity is designed to meet the needs of physicians, physician assistants, pharmacists, registered nurses, advance practice registered nurses, nurse practitioners and registered dietitians seeking to develop an expertise in clinical Lipidology.

Pricing*
Member cost: $550
Non-Member cost: $950
Trainee cost: $0

*Pricing subject to change

At the conclusion of this activity, participants should be able to:

Learning Objectives

Upon completion of the educational activity, participants should be able to:

  • Explain the pathogenesis of atherosclerosis, including the role of inflammation;
  • Describe the functions and sources of cholesterol and triglycerides including the role of lipoproteins in atherosclerosis;
  • Review basic principles of statistics in clinical trials;
  • Discuss key clinical trials of lipid-altering drug therapies used in cardiovascular disease prevention;
  • Appraise clinical trial design and methods in published literature;
  • Recognize the role of drug therapy in the management of dyslipidemia;
  • Review types of pharmacotherapy with lipid-related impacts;
  • Review the mechanism of action, pharmacokinetics, and efficacy of approved drugs for the management of dyslipidemia;
  • Council patients on dietary recommendation for lipid management;
  • Recognize the importance of lifestyle modification in the reduction of cardiometabolic risk;
  • Compose a treatment plan for patients with complex lipid disorders;
  • Describe treatment approaches for dyslipidemia in specific populations based on age, gender, ethnicity, and cultural variable;
  • Discuss current guidelines for the management and treatment of patients with dyslipidemia;
  • Identify primary and secondary causes of dyslipidemia;
  • Compose a treatment plan for the management of dyslipidemia in specific populations;
  • Compose a treatment plan for reducing risk of CVD in patients with dyslipidemia.

CME/CE credit provided by the National Lipid Association 

 

 

In support of improving patient care, this activity has been planned and implemented by The National Lipid Association. The National Lipid Association is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Credit Designation Statement
The National Lipid Association designates this live activity for a maximum of 12.25 AMA PRA Category 1 Credit(s). Physicians should claim only credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 12.25 AMA PRA Category 1 Credits™ MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Physician Assistants
NCCPA accepts AMA PRA Category I Credit™ from organizations accredited by ACCME.

Dietitians
The National Lipid Association is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR). Registered dietitians (RDs) and dietetic technicians, registered (DTRs) will receive 12.25 continuing professional education units (CPEUs) for completion of this program/ materials. CDR Accredited Provider #NL002.

Pharmacists

Universal Activity Number – UAN JA0007192-0000-24-032-L01-P (Application)
This Activity has been approved for 12.25 contact hour(s) (1.225 CEUs) of the Accreditation Council for Pharmacy Education.

Nursing
The maximum number of hours awarded for this CE activity is 12.3 contact hours.
Pharmacotherapy contact hours for Advance Practice Registered Nurses to be determined.

 

 

CRITERIA FOR SUCCESS:
Statements of credit will be awarded based on the participant´s attendance and submission of the activity evaluation form. A statement of credit will be available upon completion of an online evaluation/claimed credit form at www.lipid.org/cme. The deadline to claim credit is October 6, 2024. Questions related to this content should be sent to cme@lipid.org.

 

FOR PHARMACISTS: Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 4 weeks.

FOR DIETITIANS: Upon completion of the activity evaluation form, dietitians may submit evaluations of the quality of activities/materials to CDR. Poor evaluations of activities/materials may trigger an audit of the activities / materials by CDR.

COMMERCIAL SUPPORT
Full notification of commercial support will be provided in the meeting application.

DISCLOSURE OF UNLABELED USE AND INVESTIGATIONAL PRODUCTS
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLOSURE DECLARATION
It is the policy of NLA to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. Planners, faculty, reviewers, and staff have disclosed any financial relationships with commercial interests as defined by the ACCME

DISCLAIMER
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. The NLA specifically disclaims responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through reader’s misunderstanding of content.

PERMISSIONS
The National Lipid Association acknowledges that permissions have been obtained for use of all copyrighted materials, including graphs, tables, pictures, and charts printed in this activity syllabus. Permissions have also been obtained from identifiable patients in photographs and other images, consistent with the DHHS HIPAA regulations for individual privacy.

Carol F. Kirkpatrick, PhD, MPH, RDN, CLS, FNLA

Clinical Scientist
Midwest Biomedical Research
Addison, IL
Adjunct Faculty
Kasiska Division of Health Science, Idaho State University
Pocatello, ID 

Joseph J. Saseen, PharmD, CLS, FNLA

Chair
Professor and Vice Chair
Skaggs School of Pharmacy and Pharmaceutical Sciences
University of Colorado
Anschutz Medical Campus
Aurora, CO

Daniel E. Soffer, MD, FNLA

Chair
Immediate Past President, National Lipid Association
University of Pennsylvania Health System
Internal Medicine/Clinical Lipidology
Perelman Center for Advanced Medicine
Philadelphia, PA

Ann Liebeskind, MD, FNLA

Founder
Mobile Health Team Lipids Clinic
Neenah, WI
Clinical Adjunct Assistant Professor
University of Wisconsin
School of Medicine and Public Health
Madison, WI

2024 Foundations of Lipidology Course

 

Thursday, September 5, 2024

Day 1

7:00 - 7:30 AM Registration & Breakfast
7:30 AM - 7:45 AM Program Overview Course Chairs
7:45 AM - 8:45 AM Atherosclerosis, Lipids and Lipoproteins, Atherogenic Dyslipidemia Daniel E. Soffer, MD, FNLA
8:45 AM - 8:55 AM Break
8:55 AM - 10:25 AM Current Lifestyle Recommendations Carol Kirkpatrick, PhD, MPH, RDN, CLS, FNLA
10:25 AM - 10:40 AM Break
10:40 AM - 11:40 AM Pharmacologic Therapies Joseph J. Saseen, PharmD, CLS, FNLA
11:40 AM - 12:15 PM Lunch
12:15 PM - 1:45 PM Pharmacologic Therapies - Continued Joseph J. Saseen, PharmD, CLS, FNLA
1:45 PM - 1:55 PM Break
1:55 PM - 2:55 PM Landmark Clinical Trials Joseph J. Saseen, PharmD, CLS, FNLA
2:55 PM - 3:10 PM Break
3:10 PM - 4:10 PM Overview of Clinical Guidelines in Lipid Management Ann Liebeskind, MD, FNLA
4:10 PM - 4:20 PM Break
4:20 PM - 5:20 PM Overview of Clinical Guidelines in Lipid Management - Continued Ann Liebeskind, MD, FNLA

Friday, September 6, 2024

Day 2

7:00 - 7:30 AM Breakfast
7:30 AM - 7:35 AM Day Overview Course Chairs
7:35 AM - 8:35 AM Lipid Management of Specific Populations Ann Liebeskind, MD, FNLA
8:35 AM - 8:45 AM Break
8:45 AM - 9:45 AM Dyslipidemia and Inherited Lipid Disorders Daniel E. Soffer, MD, FNLA
9:45 AM - 10:00 AM Break
10:00 AM - 10:45 AM Challenging Patient Case 1 Joseph J. Saseen, PharmD, CLS, FNLA, Daniel E. Soffer, MD, Carol Kirkpatrick, PhD, MPH, RDN, CLS, FNLA, Ann Liebeskind, MD, FNLA
10:45 AM - 11:30 AM Challenging Patient Case 2 Daniel E. Soffer, MD, FNLA, Ann Liebeskind, MD, FNLA, Joseph J. Saseen, PharmD, CLS, MNLA, Carol Kirkpatrick, PhD, MPH, RDN, CLS, FNLA, 
11:30 AM - 12:15 PM Challenging Patient Case 3 Carol Kirkpatrick, PhD, MPH, RDN, CLS, FNLA, Joseph J. Saseen, PharmD, CLS, FNLA, Daniel E. Soffer, MD, FNLA, Ann Liebeskind, MD, FNLA
12:15 PM - 12:30 PM Wrap-up
12:30 - 1:00 PM Lunch